Biogen boosts investment in neurology with $1 billion Ionis deal
April 20, 2018 at 08:04 AM EDT
(Reuters) - U.S. drugmaker Biogen Inc rolled out part of its $37 billion investment warchest on Friday, signing a $1 billion deal that seeks to expand on the strength of an existing partnership with Ionis Pharmaceuticals Inc.
